SecBot SecBot
10-K/A ·Filed Apr 30, 2026

PHGE

BiomX Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001213900-26-050373
Amended annual report (potential restatement)
Actionable Insight • Neutral

This is a routine administrative filing with no new financial information. The real story is the complete leadership and board turnover, plus the two recent related-party acquisitions (Zorro Net and DR. Frucht) that suggest a pivot away from the original phage therapy business. Monitor the Q1 2026 10-Q for the first financial results under the new management and the impact of these acquisitions on revenue and cash burn.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.7900
T+0 close · Apr 30, 2026 · via day close
Latest settled
−76.78%
T+60 · $0.1834
Vs SPY
−79.85%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 1 $0.7900entry
  2. T+1 · 7mo ago −5.06%α −4.72% · $0.7500
  3. T+5 · 6mo ago −20.63%α −22.98% · $0.6270
  4. T+20 · 6mo ago +31.65%α +26.38% · $1.04
  5. T+60 · 4mo ago −76.78%α −79.85% · $0.1834

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BiomX filed Amendment No. 1 to its 2025 10-K solely to add Part III items (directors, executive compensation, security ownership, related transactions, and auditor fees) that were omitted from the original filing. This is a routine administrative amendment, no financial restatements, no auditor changes, and no new financial data. The filing also includes Section 302 certifications from the new CEO and CFO, and discloses a complete board and management overhaul that occurred in Q1 2026.

Key Facts

  • Amendment adds Part III items (10-14) that were previously omitted; no financial restatements or corrections.
  • Entire prior management team resigned: CEO Jonathan Solomon (March 4, 2026), CFO Marina Wolfson (Feb 24, 2026), CDO Dr. Merav Bassan (Feb 24, 2026).
  • New CEO Michael Oster and CFO David Rokach appointed; entire board replaced between Jan-Mar 2026.
  • Prior board members (7 total) all resigned between Feb 9 and March 4, 2026; new board of 4 directors appointed.
  • Director Amir Shalom resigned April 29, 2026 after only 55 days on the board.
  • Company completed two related-party acquisitions in April 2026: Zorro Net Ltd. from Water IO Ltd. (1.3M shares + $1.25M note) and 60% of DR. Frucht Systems Ltd. from Mandragola Ltd. ($750K cash + $3M convertible note + 923K shares + warrants).
  • Auditor remains Kesselman & Kesselman (PwC Israel); audit fees unchanged at $190K for both 2025 and 2024.
  • 10,111,516 shares outstanding as of April 30, 2026; market cap ~$4M.
  • CEO and CFO surrendered shares for cancellation on April 24, 2026 (10,000 and 5,000 shares respectively), now hold zero shares.

Financial Impact

No financial data in this amendment; the original 10-K financials are unchanged.

Risk Factors

  • Complete management and board turnover in Q1 2026 raises governance and strategic continuity concerns.
  • Director Amir Shalom's resignation after only 55 days without explanation is a red flag.
  • Related-party acquisitions (Water IO, Mandragola) with interlocking director relationships create conflict-of-interest risk.
  • Company has a $4M market cap with significant dilution potential from outstanding warrants and convertible notes.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
10-K/A Filing (Primary)0001213900-26-050373
Document: ea028831201ex31-2.htm0001213900-26-050373
Document: ea028831201ex31-1.htm0001213900-26-050373
Document: 0001213900-26-050373-index-headers.html0001213900-26-050373
Document: 0001213900-26-050373-index.html0001213900-26-050373
Document: 0001213900-26-050373.txt0001213900-26-050373

US Market Status

Market Closed · Opens in 4h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026